SCHEMBL27188337

SCHEMBL27188337

Cc1cncc(-c2nc3cc(NC(=O)O)ccc3o2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 1/20 0.63
▸ ALDH1A1 P00352 11/20 0.59
▸ SMN1; SMN2 Q16637 9/20 0.59
▸ KDM4E B2RXH2 9/20 0.59
▸ NPC1 O15118 8/20 0.59
▸ RAB9A P51151 8/20 0.59
▸ POLB P06746 5/20 0.59
▸ SAE1 Q9UBE0 1/20 0.59
▸ UBA2 Q9UBT2 1/20 0.59
▸ HSD17B10 Q99714 7/20 0.58
▸ HPGD P15428 6/20 0.58
▸ TP53 P04637 5/20 0.58
▸ NPSR1 Q6W5P4 3/20 0.58
▸ TSHR P16473 3/20 0.58
▸ GAA P10253 1/20 0.58
▸ THRB P10828 1/20 0.58
▸ MAPT P10636 5/20 0.57
▸ CASP3 P42574 1/20 0.54
▸ SENP8 Q96LD8 1/20 0.54
▸ SENP7 Q9BQF6 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30782718 0.86 PPARG (0.57) PPARGALDH1A1SMN1; SMN2KDM4ENPC1
SCHEMBL29000625 0.83 KDM4E (0.77) ALDH1A1SMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL30402575 0.80 KDM4E (0.81) PPARGALDH1A1SMN1; SMN2KDM4ENPC1
SCHEMBL17544225 0.80 KDM4E (0.81) PPARGALDH1A1SMN1; SMN2KDM4ENPC1
SCHEMBL27188316 0.79 PPARG (0.77) PPARGALDH1A1SMN1; SMN2KDM4ENPC1
SCHEMBL30782708 0.79 PPARG (1.00) PPARGTP53MAPT
SCHEMBL27188274 0.79 PPARG (1.00) PPARGTP53MAPT
SCHEMBL27188311 0.78 TP53 (0.68) PPARGALDH1A1SMN1; SMN2KDM4ENPC1
SCHEMBL27188301 0.78 PPARG (0.64) PPARGALDH1A1SMN1; SMN2KDM4ENPC1
SCHEMBL29327596 0.77 PPARG (0.57) PPARGKDM4ENPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109850-A1 Covalent PPARG inverse-agonists BAYER AKTIENGESELLSCHAFT (DE) 2024-04-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109850-A1 Covalent PPARG inverse-agonists PPARG, PPARD, PPARA PPARG 1/4885ALDH1A1 1224/4885SMN1; SMN2 3777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback